As skill shortages, retirements, and talent pipeline challenges converge, the workers’ comp industry faces a workforce crisis — but targeted strategies can help attract and retain next-generation professionals.

While the recent rescheduling of marijuana mainly applies to medical products and not recreational use, it does introduce significant implications for clinical research, drug development, and downstream utilization in patient care.

The liability insurance market faces challenges, with nuclear verdicts skyrocketing and premiums climbing. Litigation is unlikely to improve, making robust risk management essential.

Occupational lung diseases make up a small but significant portion of workers’ comp claims, and an uptick in wildfires across the U.S. has increased the frequency of these claims among firefighters.

As consolidation reshapes the healthcare landscape, buyers and sellers face unique insurance risks that standard policies were never designed to address.

Demand for DME is rising, as are costs. What’s driving this growth, and how can the workers’ compensation industry contain costs?

AI is no longer experimental—so where is it actually delivering results, and what separates leaders from laggards?

With the workforce growing older, degenerative conditions may have a growing impact on claims. Here are six common conditions that injured workers face.

Crawford & Company’s recent restructuring creates a unified U.S. business.

Explore the top five major findings from this year’s Workers’ Comp Industry Insights Survey

As severe weather events grow more destructive in many regions, proactive risk mitigation has become essential for protecting commercial properties.

Utah’s prescription renewal pilot is a groundbreaking use case for AI in healthcare. What are the potential benefits and pitfalls?

As artificial intelligence reshapes the insurance landscape, insurers that fail to account for change management, data integrity, and regulatory oversight risk costly missteps.

While cases may be few, long COVID can significantly impact workers’ comp claims in several ways.

Industry experts discuss the evolution of claims management as organizations leverage AI to support adjusters, not replace them, while improving outcomes for all stakeholders.

The FDA has approved the first oral version of a GLP-1 for the treatment of obesity. What do you need to know about safety, efficacy, and cost?

Early MRI evaluation and clear communication about injury timing can help adjusters and providers make better care decisions and potentially reduce costs for WC systems.

In workers’ comp, comorbidities like hypertension require a focus on drug-drug and drug-disease interactions to ensure effective and safe treatment plans.

How carriers are differentiating themselves in an increasingly complex marketplace by leveraging expertise, financial stability, and dedicated talent.

Musculoskeletal disorders plague American workers, but new diagnostic approaches give safety leaders practical tools to identify and address ergonomic risks before injuries occur.